Plant-derived Recombinant Human Serum Albumin Injection (HY1001 project) Clinical Trials Phase II Data Progress Report September 26th, China Health Ecology Organization (CHEO) was grandly held in Bo’ao. At the Pharmaceutical Innovation and Capital Market sub-forum of the China Pharmaceutical Innovation Ecological conference (CPIE), which is the one of the six core summits of CHEO, Professor... Posted by Site editor|2021-09-27 LearnMore
Application of plant-derived Recombinant Fibronectin in diagnose reagents Fibronectin (Fn), is mainly synthesized by liver and vascular endothelial cells, and widely found in animal plasma, body fluids and tissues. It's a large molecular glycoprotein with a molecular weight of 220-250 KD in monomer, 450 KD in dimer, and has various biological activ... Posted by Site editor|2020-02-21 LearnMore
Recombinant human serum albumin OsrHSA successfully obtained the DMF from U.S. FDA OsrHSA(excipient grade), plant-derived recombinant human serum albumin independently developed by Wuhan Healthgen Biotechnology Corp.(hereinafter referred to as Healthgen Biotech), has officially passed the US Food and Drug Administration (FDA) certification and successfully obta... Posted by Site editor|2015-12-16 LearnMore
Healthgen Biotech Project HY-1003 Obtained the Orphan Drug Designation from U.S. FDA February 19, 2020, the project HY-1003, Recombinant human Alpha-1 Antitrypsin, a new bio-pharmaceutical independently developed by Wuhan Healthgen Biotechnology Corp.( hereinafter referred to as Healthgen Biotech) by its State-of-the-Art plant expression platform, had obtained th... Posted by Site editor|2020-03-25 LearnMore
Healthgen Biotech Has Gained The Clinical Trial License of A New Bio-innovative Drug May 13th, 2020, Wuhan Healthgen Biotechnology Corp.( hereinafter referred to as Healthgen Biotech) received the Clinical Trial Notice of its new bio-innovative drug - Recombinant Human Lactoferrin and Lysozyme Oral Liquid (Project No. HY1002) from the Center for Drug Evaluation o... Posted by Site editor|2020-05-13 LearnMore
Pre 1 2 3 4 5 6 Next

Wuhan Healthgen Biotechnology Corp.

Tel. +86 027 59301891 Ext 8015

Fax. +86 027 59403931

E-mail cjing@oryzogen.com

268 Shendun 5th Road, East Lake High-Tech Development Zone, Wuhan, China 430020

Copyright ® Wuhan Healthgen Biotechnology Corp. All rights reserved. Terms and Conditions of Use
鄂ICP备12013293号-3